Guo Rui, Feng Xiaobin, Xiao Senlin, Yan Jun, Xia Feng, Ma Kuansheng, Li Xiaowu
Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University.
Biosci Trends. 2015 Feb;9(1):65-72. doi: 10.5582/bst.2014.01142.
The objective of this study was to compare the short- and long-term outcomes of radiofrequency-assisted liver resection (RFLR) and conventional clamp-crushing liver resection (CCLR) and to evaluate the safety and efficiency of RFLR. Between January 2008 and December 2012, a total of 597 patients with hepatocellular carcinoma (HCC) who underwent curative hepatectomy were identified. A total of 272 patients underwent RFLR, and 325 patients received CCLR. The short- and long-term outcomes were compared. The patients in the RFLR and CCLR groups showed similar baseline characteristics. The RFLR group showed less intraoperative blood loss (485.5 vs. 763.2 mL, p = 0.003), a lower transfusion requirement rate (19.1 vs. 31.7%, p ≤ 0.01), shorter surgery duration (211 vs. 296 min, p ≤ 0.01) and a lower vascular inflow occlusion rate (25.7 vs. 33.8%, p = 0.032). No significant postoperative changes in bilirubin or liver enzymes were observed in the two groups. The degree of postoperative complications and morbidity did not significantly differ between the two groups. There were no significant differences in the 1-, 2- and 3-year overall survival rates (73.8%, 58.5%, and 55.7% vs. 80.8%, 65.8%, and 56.2%, respectively) or disease-free rates (51.9%, 47.2%, and 46.0% vs. 54.5%, 44.9%, and 38.5%, respectively) between the RFLR and CCLR groups. These results suggested RFLR was a safe and efficient method for patients with HCC. RFLR was associated with decreased blood loss, fewer blood transfusions, shorter surgery times and less vascular inflow occlusion application. The RFLR group did not show increased liver injury or postoperative morbidity or mortality.
本研究的目的是比较射频辅助肝切除术(RFLR)和传统钳夹挤压肝切除术(CCLR)的短期和长期疗效,并评估RFLR的安全性和有效性。2008年1月至2012年12月期间,共确定了597例行根治性肝切除术的肝细胞癌(HCC)患者。其中272例患者接受了RFLR,325例患者接受了CCLR。比较了两组的短期和长期疗效。RFLR组和CCLR组患者的基线特征相似。RFLR组术中出血量较少(485.5 vs. 763.2 mL,p = 0.003),输血需求率较低(19.1% vs. 31.7%,p≤0.01),手术时间较短(211 vs. 296分钟,p≤0.01),血管流入阻断率较低(25.7% vs. 33.8%,p = 0.032)。两组术后胆红素或肝酶均无明显变化。两组术后并发症程度和发病率无显著差异。RFLR组和CCLR组在1年、2年和3年总生存率(分别为73.8%、58.5%和55.7% vs. 80.8%、65.8%和56.2%)或无病生存率(分别为51.9%、47.2%和46.0% vs. 54.5%、44.9%和38.5%)方面无显著差异。这些结果表明,RFLR对HCC患者是一种安全有效的方法。RFLR与出血量减少、输血次数减少、手术时间缩短和血管流入阻断应用减少有关。RFLR组未显示肝损伤增加或术后发病率或死亡率增加。